Jack Yongfeng Zhang
2018
In 2018, Jack Yongfeng Zhang earned a total compensation of $5.9M as Chief Executive Officer, Chief Scientific Officer and Director at Amphastar Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
Bonus | $888,331 |
---|---|
Option Awards | $1,940,009 |
Salary | $1,091,539 |
Stock Awards | $1,939,994 |
Other | $14,834 |
Total | $5,874,707 |
Zhang received $1.9M in option awards, accounting for 33% of the total pay in 2018.
Zhang also received $888.3K in bonus, $1.1M in salary, $1.9M in stock awards and $14.8K in other compensation.
Rankings
In 2018, Jack Yongfeng Zhang's compensation ranked 1,613th out of 14,244 executives tracked by ExecPay. In other words, Zhang earned more than 88.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,613 | 89th |
Manufacturing | 570 | 90th |
Chemicals And Allied Products | 179 | 92nd |
Drugs | 142 | 92nd |
Pharmaceutical Preparations | 104 | 93rd |
Zhang's colleagues
We found two more compensation records of executives who worked with Jack Yongfeng Zhang at Amphastar Pharmaceuticals in 2018.
News
Amphastar Pharmaceuticals CEO Jack Zhang's 2021 pay rises 9% to $6.5M
April 14, 2022
Amphastar Pharmaceuticals General Counsel Jason Shandell's 2020 pay jumps 132% to $6.8M
April 14, 2021
Amphastar Pharmaceuticals CEO Jack Zhang's 2019 pay rises 2% to $6M
April 15, 2020
Amphastar Pharmaceuticals CEO Jack Zhang's 2018 pay rises 2% to $5.9M
April 18, 2019